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General Information. 
All reactions were carried out in dry glassware under an argon atmosphere using standard 
Schlenk line techniques or in a Vacuum Atmospheres Glovebox under a nitrogen atmosphere unless 
otherwise specified. All solvents were purified by passage through solvent purification columns and 
further degassed with argon.1 NMR solvents for air-sensitive compounds were dried over CaH2 and 
vacuum transferred or distilled into a dry Schlenk flask and subsequently degassed with argon. 
Commercially available reagents were used as received unless otherwise noted. Substrates for olefin 
cross-metathesis (12, 15, 17-24, 26, 27) were degassed with argon and passed through a plug of neutral 
alumina (Brockmann I) prior to use. Complex 2 was synthesized according to the literature procedure.2 
 Standard NMR spectroscopy experiments were conducted on a Varian Inova 400 MHz 
spectrometer, while kinetic experiments were conducted on a Varian 500 MHz spectrometer equipped 
with an AutoX probe. Experiments and pulse sequences from Varian’s Chempack 4 software were used. 
Chemical shifts are reported in ppm downfield from Me4Si by using the residual solvent peak as an 
internal standard. Spectra were analyzed and processed using MestReNova Ver. 7.3  
Gas chromatography data was obtained using an Agilent 6850 FID gas chromatograph equipped 
with a DB-Wax Polyethylene Glycol capillary column (J&W Scientific).  
High-resolution mass spectrometry (HRMS) data was obtained on a JEOL MSRoute mass 






                                                     
(1)  Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518.  
(2) Endo, K.; Grubbs, R. H. J. Am. Chem. Soc. 2011, 133, 8525.  
(3) www.mestrelab.com  
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Preparation of 3. 
 In a glovebox, a 250 mL RB flask was charged with 2 (491 mg, 0.731 mmol), NaI (548 mg, 3.65 
mmol), and THF (25 mL). The resulting suspension was stirred for 1 h, at which point a color change from 
purple to brown had occurred. The solution was concentrated and the residue was dissolved in CH2Cl2 
(ca. 100 mL), filtered through celite, and concentrated to a brown residue which was triturated with Et2O 
until the washes were colorless to give 3 (332 mg, 65%) as a brown solid. 1H NMR (400 MHz, C6D6) δ 
13.42 (s, 1H), 7.38 (dd, J = 8, 4 Hz, 1H), 7.15 (m, 1H), 6.97 (br s, 1H), 6.80 (dt, J = 8, 1 Hz, 1H), 6.76 (br 
s, 1H), 6.64 (d, J = 8 Hz, 1H), 4.81 (sept, J = 4 Hz, 1H), 3.46 (q, J = 8 Hz, 1H), 3.37-3.30 (m, 1H), 3.11-
3.06 (m, 2H), 2.61 (br s, 1H), 2.56 (s, 3H), 2.41 (s, 3H), 2.40 (br s, 1H), 2.13 (s, 3H), 2.03 (br s, 1H), 1.91 
(d, J = 4 Hz, 3H), 1.86-1.79 (m, 2H), 1.65 (br s, 2H), 1.62 (d, J = 4 Hz, 3H), 1.59-1.57 (m, 1H),1.43-1.37 
(m, 3H), 2.30 (br d, J = 8 Hz, 2H), 0.54 (br d, J = 16 Hz, 1H). 13C NMR (126 MHz, C6D6) δ 236.56, 215.48, 
154.59, 141.54, 139.13, 138.09, 137.45, 135.36, 125.96, 123.47, 122.63, 112.99, 81.52, 75.78, 63.40, 
52.52, 42.24, 41.09, 39.39, 38.12, 37.54, 37.25, 33.81, 30.63, 29.64, 22.72, 21.76, 21.16, 20.99, 19.28. 
HRMS (FAB+): Calculated – 698.1316, Found – 698.1343. 
 
 
Preparation of silver(I) 2,2-dicyclohexylacetate (4-Ag).   
 To 2,2-dicyclohexylcarboxylic acid (1.24 g, 5.54 mmol) and NaOH (193 mg, 4.82 mmol) was 
added H2O (2.7 mL) and the solution was stirred for 15 min. AgNO3 (676 mg, 3.99 mmol) dissolved in 
H2O (2.6 mL) was added dropwise which caused immediate precipitation of a white solid. The suspension 
was stirred for 15 min after which the white precipitate was collected on a medium porosity frit and 
washed with H2O, MeOH, and hexanes. After drying, 4-Ag was recovered as a white solid (937 mg, 
71%). Insolubility precluded analysis using NMR spectroscopy. MS (Laser Desorption Ionization): 





Preparation of 4. 
 In a glovebox, a 20 mL scintillation vial was charged with 3 (24 mg, 0.035 mmol) and 4-Ag (13 
mg, 0.038 mmol). THF (ca. 1 mL) was added and the color of the solution immediately changed from 
brown to deep purple. The reaction was stirred for 1 h and concentrated. The resulting purple residue was 
dissolved in C6H6, filtered through celite, and concentrated to give 4 (25 mg, 93%).  
 Note: Catalyst 4 would change colors from purple to brown upon the addition of solvents which 
were not rigorously purified of oxygen. Recrystallization from Et2O at 35°C was used to purify 4 when 
this occurred. 1H NMR (400 MHz, C6D6) δ 14.94 (s, 1H), 7.41 (dd, J = 8, 4 Hz, 1H), 7.25 (dt, J = 8, 4 Hz, 
1H), 6.87-6.83 (m, 2H), 6.80 (br s, 1H), 6.72 (br d, J = 8 Hz, 1H), 4.78 (sept, J = 8 Hz, 1H), 4.08 (s, 1H), 
3.45-3.13 (m, 4H), 2.47 (br s, 1H), 2.44 (s, 3H), 2.33 (s, 1H), 2.25 (s, 1H), 2.10-1.30 (m, 10H), 2.07 (br s, 
1H), 1.98 (br d, J = 8 Hz, 3H), 1.88 (br d, J = 8 Hz, 4H), 1.79 (br s, 3H), 1.76 (br s, 2H), 1.64 (br s, 4H), 
1.60 (d, J = 4 Hz, 4H), 3.34 (br d, J = 16 Hz, 3H), 1.39 (br s, 1H), 1.36 (d, J = 4 Hz, 5H), 1.17 (br d, J = 8 
Hz, 2H), 1.07 (br d, J = 8 Hz, 2H), 0.63 (br d, J = 12 Hz, 1H).  13C NMR (101 MHz, C6D6) δ 258.83, 
214.74, 183.61, 153.90, 143.52, 137.70, 136.58, 136.43, 136.03, 129.47, 129.20, 124.98, 122.86, 122.83, 
113.34, 73.83, 67.67, 62.30, 57.15, 51.31, 42.77, 40.96, 40.04, 37.88, 37.58, 36.76, 33.30, 30.71, 29.60, 
21.68, 21.35, 20.86, 18.65, 18.49. HRMS (FAB+, (M+H)H2): Calculated – 793.3883, Found – 793.3894. 
 
 
Preparation of 5.  
 Catalyst 5 (23 mg, 80%) was prepared in a manner analogous to catalyst 4. 3 (32 mg, 0.046 
mmol), AgOAc (11 mg, 0.069 mmol), THF (ca. 1 mL). 1H NMR (400 MHz, C6D6) δ 14.95 (s, 1H), 7.47 (dd, 
J = 7.6, 1.6 Hz, 1H), 7.25 (t, J = 7.2 Hz, 1H), 6.88 (dt, J = 7.6, 1.2 Hz, 1H), 6.77 (br s, 1H), 6.70 (br s, 1H), 
6.65 (br d, J = 8.4 Hz, 1H), 4.76 (sept, J = 6.0 Hz, 1H), 4.06 (s, 1H), 3.47 (q, J = 8.8 Hz, 1H), 3.38-3.21 
(m, 4H), 2.43 (s, 3H), 2.40 (br s, 1H), 2.33 (s, 3H), 2.15 (br s, 4H), 2.15-1.04 (m, 2H), 1.98-1.95 (m, 1H), 
1.87-1.83 (m, 1H), 1.78 (s, 3H), 1.69 (br s, 1H), 1.57 (d, J = 6.4 Hz, 3H), 1.56-1.53 (m, 2H), 1.22-1.15 (m, 
2H), 1.05 (d, J = 6.4 Hz, 3H), 0.73 (br d, J = 12 Hz, 1H).  13C NMR (101 MHz, C6D6) δ 259.69, 215.65, 
180.15, 154.57, 143.79, 137.76, 137.41, 136.81, 136.42, 129.55, 129.24, 125.51, 123.20, 123.19, 112.90, 
74.01, 68.79, 67.84, 62.82, 51.44, 43.38, 41.62, 40.64, 38.27, 37.97, 37.72, 33.59, 31.21, 30.03, 25.84, 






Preparation of silver(I) 2,2-dimethoxypropanoate (6-Ag).  
 A 100 mL RB flask was charged with 2,2-dimethoxypropanoic acid (488 mg, 3.64 mmol), Ag2O 
(507 mg, 2.19 mmol), MeCN (20 mL), and H2O (6 mL). The solution was shielded from light and stirred at 
RT under Ar for 5 h. The suspension was filtered through celite, washing with MeCN, and the filtrate was 
concentrated to a white solid which was washed with hexanes and collected by filtration to give 6-Ag (469 
mg, 53%). 1H NMR (400 MHz, D2O) δ 3.21 (s, 6H), 1.43 (s, 3H). 13C NMR (101 MHz, D2O) δ 176.37, 
101.51, 49.34, 20.26. MS (Laser Desorption Ionization): Calculated – 133.0506, Found – 133.0539. 
 
 
Preparation of 6.  
 Catalyst 6 (31 mg, 89%) was prepared in a manner analogous to catalyst 4. 3 (35 mg, 0.050 
mmol), 6-Ag (13 mg, 0.055 mmol), THF (ca. 1 mL). 1H NMR (600 MHz, C6D6) δ 14.88 (s, 1H), 7.43 (br d, 
J = 12 Hz, 1H), 7.23 (t, J = 6 Hz, 1H), 6.94 (br s, 1H), 6.86 (t, J = 6 Hz, 1H), 6.74-6.71 (m, 2H), 4.87 (br s, 
1H), 4.16 (s, 1H), 3.50-3.19 (m, 10H), 2.47 (br s, 1H), 2.45 (s, 3H), 2.40 (s, 3H), 2.20 (s, 3H), 2.13-2.08 
(m, 2H), 2.01 (br d, J = 12 Hz, 1H), 1.96 (br d, J = 12 Hz, 1H), 1.82 (br d, J = 12 Hz, 1H), 1.66 (br s, 1H), 
1.63 (d, J = 6 Hz, 3H), 1.57-1.54 (m, 1H), 1.50-1.48 (m, 1H), 1.43 (br d, J = 12 Hz, 1H), 1.38 (s, 3H), 1.27 
(br d, J = 6 Hz, 3H), 1.17 (br d, J = 12 Hz, 1H), 1.10-1.09 (m, 2H), 0.68 (br d, J = 6 Hz, 1H).  13C NMR 
(151 MHz, C6C6) δ 259.06, 216.37, 177.95, 154.78, 144.04, 138.48, 137.86, 136.61, 136.38, 130.46, 
129.48, 125.96, 123.52, 123.39, 113.89, 99.58, 75.37, 69.60, 63.10, 51.94, 43.58, 41.83, 40.83, 38.50, 
38.32, 37.63, 33.94, 31.45, 30.30, 21.70, 21.41, 21.17, 20.99, 19.11, 18.88. HRMS (FAB+, (M+H)H2): 





Preparation of 7.  
 Method A: In a glovebox, a 20 mL scintillation vial was charged with 3 (112 mg, 0.161 mmol), 
AgNO3 (409 mg, 2.41 mmol), and THF (6 mL). The reaction was stirred vigorously until a color change 
from brown to dark purple was observed (ca. 3-5 min). At this point, the reaction was immediately 
concentrated and the resulting residue was dissolved in C6H6, filtered, and concentrated. The crude 
product was triturated with Et2O several times, until the washes were colorless, to give 7 (73 mg, 72%) as 
a purple solid.  1H NMR (400 MHz, C6D6) δ 15.22 (s, 1H), 7.37 (d, J = 7.2 Hz, 1H), 7.18 (t, J = 7.6 Hz, 1H), 
6.98 (s, 1H), 6.82 (t, J = 7.6 Hz, 1H), 6.66 (s, 1H), 6.48 (d, J = 8.4 Hz, 1H), 4.57 (sept, J = 6.0 Hz, 1H), 
4.17 (s, 1H), 3.43 (q, J = 9.6 Hz, 1H), 3.28 – 3.15 (m, 3H), 2.38 (d, J = 8.4 Hz, 6H), 2.25 (br s, 1H), 2.15 – 
2.09 (m, 4H), 2.03 – 1.97 (m, 2H), 1.90 – 1.87 (m, 1H), 1.77 (br d, J = 15.2 Hz, 1H), 1.65 (br s, 1H), 1.55 
– 1.47 (m, 2H), 1.42 (d, J = 5.2 Hz, 3H), 1.14 – 1.10 (m, 3H), 0.96 (d, J = 6.0 Hz, 3H), 0.58 (br d, J = 12 
Hz, 1H).  13C NMR (101 MHz, C6D6) δ 265.80, 265.55, 214.16, 154.72, 143.60, 137.69, 137.40, 136.24, 
135.45, 130.11, 129.36, 126.83, 123.38, 123.35, 113.00, 74.32, 66.78, 63.05, 51.36, 43.14, 41.84, 40.34, 
37.95, 37.81, 37.65, 33.33, 30.98, 29.83, 21.25, 21.09, 20.28, 18.56, 17.44. HRMS (FAB+, MNO3): 
Calculated – 571.2263, Found – 571.2273. 
 Method B: In a glovebox, a 20 mL scintillation vial was charged with 2 (128 mg, 0.190 mmol), 
NH4NO3 (457 mg, 5.71 mmol), and THF (ca. 10 mL). The reaction was stirred until completion as 
determined by 1H NMR spectroscopy (ca. 1h) and concentrated. The residue was purified as described in 





Scheme S1. Synthesis of catalysts 8, 9, and 10. 
 
Preparation of S1. 
A solution of 2,6-diethyl-4-methylaniline (1.63 g, 10.0 mmol) and CH3CN (20 mL) was treated with 
K2CO3 (2.76 g, 20.0 mmol). Bromoacetyl chloride (830 ul, 10.0 mmol) was added dropwise, and the 
reaction mixture was stirred at 25 °C over 12-16 h. The mixture was filtered over celite, concentrated 
under reduced pressure, and recrystallized from CH2Cl2-hexanes providing S1 (1.55 g, 55%) as a white 
powder: 1H NMR (CDCl3, 500 MHz) δ 7.68 (s, 1H), 6.95 (s, 2H), 4.08 (s, 2H), 2.54 (q, 4H, J = 7.5 Hz), 
2.32 (s, 3H), 1.19 (t, 6H, J = 7.5 Hz); 13C NMR (CDCl3, 125 MHz) δ 164.8, 141.2, 138.2, 129.1, 127.4, 




Preparation of S2.  
Prepared from 4-methoxy-2,6-dimethylaniline4 (520 mg, 3.44 mmol) and bromoacetyl chloride 
(286 ul, 3.44 mmol) following the procedure detailed for S1 providing S2 (750 mg, 80%) as a white 
powder: 1H NMR (CDCl3, 500 MHz) δ 7.66 (s, 1H), 6.62 (s, 2H), 4.04 (s, 2H), 3.77 (s, 3H), 2.20 (s, 6H); 
13C NMR (CDCl3, 125 MHz) δ 164.5, 158.7, 136.9, 125.9, 113.6, 55.4, 29.2, 18.6; HRMS (EI+) m/z: 
Calculated 271.0208, Found 271.0198. 
 
Preparation of S3.  
Prepared from 4-chloro-2,6-dimethylaniline (1.55 g, 3.44 mmol) and bromoacetyl chloride (286 ul, 
10.0 mmol) following the procedure detailed for S1 providing S3 (0.75 g, 28%) as a white powder: 1H 
NMR (CDCl3, 300 MHz) δ 7.10 (s, 2H), 4.07 (s, 2H), 2.22 (s, 6H); 13C NMR ((CD3)2SO, 125 MHz) δ 
164.9, 137.5, 133.3, 130.7, 127.3, 29.1, 17.6; HRMS (FAB+) m/z: Calculated 277.9761, Found 277.9755. 
 
Preparation of S4.  
A solution of S1 (950 mg, 3.36 mmol) and 1-adamantylamine (760 mg, 5.0 mmol) in CH3CN (10 
mL) was treated with K2CO3 (700 mg, 5.1 mmol) and allowed to stir at 85 °C for 16 h. The reaction 
mixture was then filtered over celite and concentrated under reduced pressure. Flash chromatography 
(SiO2, 4% MeOH-DCM) provided S4 (1.11 g, 93%) as a white solid: 1H NMR (CDCl3, 500 MHz) δ 9.04 (s, 
1H), 6.93 (s, 2H), 3.42 (s, 2H), 2.54 (q, 4H, J = 7.5 Hz), 2.31 (s, 3H), 2.11 (br s, 3H), 1.58-1.73 (m, 13H), 
1.17 (t, 6H, J = 7.5 Hz); 13C NMR (CDCl3, 125 MHz) δ 172.2, 140.9, 137.1, 130.2, 127.2, 51.1, 44.1, 42.9, 
36.5, 29.5, 25.1, 21.2, 14.7; HRMS (FAB+) m/z: Calculated ([M + H]) 355.2749, Found 355.2758 ([M + 
H]).  
 
Preparation of S5.  
Prepared from S2 (700 mg, 2.58 mmol) and 1-adamantylamine (590 mg, 3.9 mmol) following the 
procedure detailed for S4 providing S5 (800 mg, 91%) as an off-white solid: 1H NMR (CDCl3, 500 MHz) δ 
8.94 (s, 1H), 6.62 (s, 2H), 3.75 (s, 3H), 3.40 (s, 2H), 2.18 (s, 6H), 2.10 (br m, 3H), 1.57-1.71 (m, 13H); 13C 
NMR (CDCl3, 125 MHz) δ 171.9, 158.1, 136.4, 127.0, 113.4, 55.3, 51.1, 44.0, 42.9, 36.5, 29.5, 18.9; 
HRMS (EI+) m/z: Calculated 342.2307, Found 342.2292. 
Preparation of S6.  
Prepared from S3 (750 mg, 2.73 mmol) and 1-adamantylamine (620 mg, 4.1 mmol) following the 
procedure detailed for S4 providing S6 (715 mg, 77%) as a white solid: 1H NMR (CDCl3, 500 MHz) δ 9.06 
(s, 1H), 7.05 (s, 2H), 3.41 (s, 2H), 2.18 (s, 6H), 2.10 (br m, 3H), 1.57-1.71 (m, 13H); 13C NMR (CDCl3, 125 
MHz) δ 171.6, 136.9, 132.8, 132.1, 128.0, 51.2, 44.1, 42.9, 36.5, 29.5, 18.6; HRMS (EI+) m/z: Calculated 
347.1890, Found 347.1905. 
                                                     
(4) Blum, A. P.; Ritter, T.; Grubbs, R. H. Organometallics 2007, 26, 2122.  
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Preparation of S7.  
Under an atmosphere of argon, a solution of S4 (1.0 g, 2.82 mmol) in THF (15 mL) at 0 °C was 
treated with LiAlH4 (325 mg, 8.5 mmol). The reaction mixture was allowed to warm to 25 °C and stirred at 
65 °C for 36 h. The reaction mixture was allowed to cool to 0 °C and 1 mL H2O and 1 mL NaOH were 
added slowly. The mixture was diluted with EtOAc, filtered, and partitioned between EtOAc-H2O. The 
organic layer was dried (Na2SO4) and concentrated under reduced pressure providing S7 (0.95 g, 99%) 
as a yellow oil: 1H NMR (CDCl3, 500 MHz) δ 6.88 (s, 2H), 2.98 (m, 2H), 2.85 (m, 2H), 2.70 (q, 4H, J = 7.5 
Hz), 2.30 (s, 3H), 2.11 (br s, 3H), 1.62-1.74 (m, 13H), 1.27 (t, 6H, J = 7.5 Hz); 13C NMR (CDCl3, 125 MHz) 
δ 142.88, 136.3, 131.5, 127.3, 51.1, 50.2, 43.0, 40.6, 36.8, 29.6, 24.4, 20.8, 15.0; HRMS (FAB+) m/z: 
Calculated ([M + H]) 341.2957, Found 341.2966 ([M + H]). 
 
Preparation of S8.  
Prepared from S5 (735 mg, 2.15 mmol) and LiAlH4 (245 mg, 6.45 mmol) following the procedure 
detailed for S7 providing S8 (685 mg, 98%) as a yellow oil: 1H NMR (CDCl3, 500 MHz) δ 6.56 (s, 2H), 
3.73 (s, 3H), 2.93 (dd, 2H, J = 6.5, 5.0 Hz), 2.79 (dd, 2H, J = 6.5, 5.0 Hz), 2.29 (s, 6H), 2.07 (br s, 3H), 
1.58-1.71 (m, 13H); 13C NMR (CDCl3, 125 MHz) δ 154.5, 139.8, 131.4, 113.8, 55.3, 50.2, 50.0, 43.0, 40.7, 
36.8, 29.6, 18.8; HRMS (FAB+) m/z: Calculated ([M + H]) 329.2593, Found 329.2577 ([M + H]). 
 
Preparation of S9.  
Prepared from S6 (660 mg, 1.91 mmol) and LiAlH4 (218 mg, 5.73 mmol) following the procedure 
detailed for S7 providing S9 (634 mg, 99%) as a yellow oil: 1H NMR (CDCl3, 500 MHz) δ 6.92 (s, 2H), 
2.96 (m, 2H), 2.75 (m, 2H), 2.25 (s, 6H), 2.05 (br s, 3H), 1.58-1.71 (m, 13H); 13C NMR (CDCl3, 125 MHz) 
δ 145.2, 130.4, 128.1, 125.5, 50.1, 49.2, 42.9, 40.3, 36.6, 29.5, 18.6; HRMS (FAB+) m/z: Calculated ([M + 
H]) 333.2098, Found 333.2094 ([M + H]). 
Preparation of S10.  
A solution of S7 (950 mg, 2.79 mmol) in Et2O (5 mL) was treated with 2M HCl in Et2O (2.80 mL) 
to provide a white solid that was filtered and dried. A solution of triethylorthoformate (5 mL) was added to 
this white solid and the mixture was allowed to stir at 120 °C for 30 min. The reaction mixture was 
concentrated under reduced pressure to provide an off-white powder that was filtered, washed with 
hexanes and dried to provide S10 (0.55 g, 52%) as a white powder: 1H NMR (CDCl3, 500 MHz) δ 8.65 (s, 
1H), 6.97 (s, 2H), 4.48 (t, 2H, J = 10.0 Hz), 4.31 (t, 2H, J = 10.0 Hz), 2.53-2.69 (m, 4H), 2.33 (s, 3H), 2.26 
(br m, 3H), 2.10 (d, 6H, J = 2.5 Hz), 1.73 (t, 6H, J = 2.5 Hz), 1.26 (t, 6H, J = 7.5 Hz); 13C NMR (CDCl3, 
125 MHz) δ 156.2, 140.9, 140.3, 129.6, 127.6, 57.9, 52.1, 45.4, 41.0, 35.3, 29.1, 24.0, 21.3, 14.8; HRMS 
(FAB+) m/z: Calculated ([M+]) 351.2800, Found 351.2817 ([M+]). 
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Preparation of S11.  
Prepared from S8 (685 mg, 2.10 mmol) and triethylorthoformate (5 mL) following the procedure 
detailed for S10 providing S11 (565 mg, 72%) as a white powder: 1H NMR (CDCl3, 500 MHz) δ 9.04 (s, 
1H), 6.49 (s, 2H), 4.27 (dd, 2H, J = 9.2, 12.3 Hz), 4.12 (dd, 2H, J = 9.2, 12.3 Hz), 3.66 (s, 3H), 2.21 (s, 
6H), 2.13 (br m, 3H), 2.01 (d, 6H, J = 3.0 Hz), 1.62 (t, 6H, J = 2.8 Hz); 13C NMR (CDCl3, 125 MHz) δ 
159.7, 156.8, 137.0, 126.5, 114.0, 57.8, 55.3, 50.9, 45.1, 40.8, 35.3, 29.1, 18.4; HRMS (FAB+) m/z: 
Calculated ([M+]) 339.2436, Found 339.2448 ([M+]). 
Preparation of S12.  
Prepared from S9 (630 mg, 1.91 mmol) and triethylorthoformate (5 mL) following the procedure 
detailed for S10 providing S12 (600 mg, 83%) as a white powder: 1H NMR (CDCl3, 500 MHz) δ 9.47 (s, 
1H), 6.98 (s, 2H), 4.26 (m, 2H), 4.14 (m, 2H), 2.24 (s, 6H), 2.14 (br s, 3H), 2.01 (d, 6H, J = 3.0 Hz), 1.63 
(t, 6H, J = 3.2 Hz); 13C NMR (CDCl3, 125 MHz) δ 157.3, 137.7, 135.1, 132.3, 128.8, 58.1, 50.6, 45.1, 
40.9, 35.3, 29.1, 18.2; HRMS (FAB+) m/z: Calculated ([M+]) 343.1941, Found 343.1932 ([M+]). 
 
 
Preparation of S13.  
In a glove box, a solution of S10 (200 mg, 0.52 mmol) in hexanes (6 mL) was treated with 
KCOMe2Et (75 mg, 0.57 mmol), and the mixture was allowed to stir at 35 °C for 1 h. The reaction mixture 
was then treated with RuCl2(PCy3)(=CH-o-OiPrC6H4) (312 mg, 0.52 mmol), removed from the glove box, 
and allowed to stir at 65 °C for 3 h. The precipitated solids were filtered and washed well with hexanes to 
provide S13 (335 mg, 96%) as a green powder: 1H NMR (CDCl3, 500 MHz) δ 16.87 (s, 1H), 7.55 (ddd, 
1H, J = 1.7, 7.4, 8.8 Hz), 7.15 (s, 2H), 6.91 (m, 2H), 6.83 (dd, 1H, J = 1.5, 7.5 Hz), 5.06 (hept, 1H, J = 6.1 
Hz), 4.02 (dd, 2H, J = 8.4, 11.4 Hz), 3.85 (dd, 2H, J = 8.4, 11.4 Hz), 2.95 (br s, 6H), 2.70 (dq, 2H, J = 7.6, 
15.3 Hz), 2.55 (dq, 2H, J = 7.6, 15.3 Hz), 2.53 (s, 3H), 2.41 (br s, 3H), 1.94 (d, 3H, J = 12.0 Hz), 1.83 (d, 
3H, J = 12.0 Hz), 1.63 (d, 6H, J = 6.1 Hz), 1.13 (t, 6H, J = 7.5 Hz); 13C NMR (CDCl3, 125 MHz) δ 311.7, 
208.6, 152.4, 145.6, 143.1, 138.63, 138.59, 130.7, 127.1, 123.6, 122.6, 113.3, 74.2, 57.7, 52.8, 44.5, 




Preparation of S14.  
Prepared from S11 (100 mg, 0.27 mmol) and RuCl2(PCy3)(=CH-o-OiPrC6H4) (160 mg, 0.27 mmol) 
following the procedure detailed for S13 providing S14 (138 mg, 78%) as a green powder: 1H NMR 
(CDCl3, 500 MHz) δ 16.98 (s, 1H), 7.56 (ddd, 1H, J = 1.9, 7.2, 8.9 Hz), 6.93 (m, 3H), 6.78 (s, 2H), 5.09 
(hept, 1H, J = 6.1 Hz), 4.04 (dd, 2H, J = 8.5, 11.9 Hz), 1.89 (s, 3H), 3.85 (dd, 2H, J = 8.5, 11.9 Hz), 2.95 
(br s, 6H), 2.41 (s, 3H), 2.26 (s, 6H), 1.93 (d, 3H, J = 12.0 Hz), 1.83 (d, 3H, J = 12.0 Hz), 1.63 (d, 6H, J = 
6.0 Hz); 13C NMR (CDCl3, 125 MHz) δ 312.4, 208.3, 159.4, 152.4, 145.92, 145.90, 139.6, 135.3, 130.8, 
124.0, 122.8, 114.0, 113.3, 74.2, 57.2, 55.7, 51.3, 44.6, 42.2, 36.2, 30.0, 22.5, 18.8; HRMS (FAB+) m/z: 
Calculated 658.1667, Found 658.1645. 
 
 
Preparation of S15.  
Prepared from S12 (100 mg, 0.27 mmol) and RuCl2(PCy3)(=CH-o-OiPrC6H4) (160 mg, 0.27 mmol) 
following the procedure detailed for S13 providing S15 (136 mg, 78%) as a green powder: 1H NMR 
(CDCl3, 500 MHz) δ 16.89 (s, 1H), 7.59 (m, 1H), 7.26 (m, 2H), 6.96 (m, 3H), 5.10 (hept, 1H, J = 6.2 Hz), 
4.05 (dd, 2H, J = 8.4, 11.6 Hz), ), 3.83 (dd, 2H, J = 8.5, 11.6 Hz), 2.93 (br s, 6H), 2.41 (s, 3H), 2.28 (s, 
6H), 1.93 (d, 3H, J = 12.0 Hz), 1.84 (d, 3H, J = 12.5 Hz), 1.63 (d, 6H, J = 6.0 Hz); 13C NMR (CDCl3, 125 
MHz) δ 310.8, 208.2, 152.4, 145.8, 140.7, 140.4, 133.9, 131.0, 128.8, 124.0, 122.9, 113.3, 74.3, 57.4, 





Preparation of 8.  
In a glovebox, a solution of S13 (98 mg, 0.14 mmol) and THF (5 mL) was treated with AgOPiv (92 
mg, 0.44 mmol). The reaction mixture was allowed to stir at 25 °C for 30 min and a color change from 
brown to purple was observed. The mixture was immediately filtered over celite and concentrated. The 
residue was triturated with Et2O and dried to provide a purple solid. The purple solid was then taken up in 
THF (3 mL), treated with NH4NO3 (350 mg, 4.4 mmol) and allowed to stir for 1 h. The reaction mixture 
was concentrated, taken up in benzene, and filtered over celite. The filtrate was dried and triturated with 
Et2O until the washes were colorless providing 8 (30 mg, 31%) as a purple powder: 1H NMR (C6D6, 500 
MHz) δ 15.19 (s, 1H), 7.42 (dd, 1H, J = 1.5, 7.5 Hz) 7.18 (ddd, 1H, J = 1.5, 7.5, 8.5 Hz), 7.06 (d, 1H, J = 
1.0 Hz), 6.83 (dt, 1H, J = 1.0, 7.5 Hz), 6.79 (d, 1H, J = 1.5 Hz), 6.47 (d, 1H, J = 8.5 Hz), 4.55 (hept, 1H, J 
= 6.3 Hz), 4.18 (s, 1H), 3.55 (q, 1H, J = 10.7 Hz), 3.39 (m, 1H), 3.17-3.29 (m, 2H), 3.06 (dq, 1H, J = 7.7, 
15.3 Hz), 2.86-3.00 (m, 2H), 2.63 (dq, 1H, J = 7.5, 15.0 Hz), 2.24 (m, 1H), 2.15 (s, 3H), 2.10 (m, 1H), 
1.96-2.02 (m, 2H), 1.89 (d, 1H, J = 11.0 Hz), 1.77 (dd, 1H, J = 1.5, 12.0 Hz), 1.66 (m, 1H), 1.44-1.55 (m, 
3H),1.42 (d, 3H, J = 6.5 Hz), 1.28 (t, 3H, J = 7.5 Hz), 1.20 (t, 3H, J = 7.5 Hz), 1.10 (m, 2H), 0.94 (d, 3H, J 
= 6.0 Hz), 0.59 (d, 1H, J = 12.0 Hz); 13C NMR (C6D6, 100 MHz) δ 214.3, 154.7, 143.54, 143.50, 141.1, 
137.8, 134.9, 128.5, 127.0, 126.8, 123.37, 123.33, 113.0, 74.3, 66.7, 63.0, 52.9, 43.0, 41.8, 40.3, 37.9, 
37.77, 37.73, 33.3, 30.9, 29.8, 24.1, 23.4, 21.4, 21.2, 20.2, 15.7, 15.3; HRMS (FAB+) m/z: Calculated 
661.2454, Found 661.2422. 
 
 
Preparation of 9.  
Prepared from S14 (118 mg, 0.179 mmol) and AgOPiv (112 mg, 0.54 mmol) following the 
procedure detailed for 8 providing 9 (16.5 mg, 14%) as a purple powder: 1H NMR (C6D6, 400 MHz) δ 
15.21 (s, 1H), 7.37 (dd, 1H, J = 1.6, 7.6 Hz), 7.19 (m, 1H), 6.82 (m, 2H), 6.44 (d, 1H, J = 2.8 Hz), 6.49 (d, 
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1H, J = 8.4 Hz), 4.58 (hept, 1H, J = 6.3 Hz), 4.16 (s, 1H), 3.40 (m, 1H), 3.33 (s, 3H), 3.10-3.30 (m, 3H), 
2.37 (d, 6H, J = 2.8 Hz), 2.24 (m, 1H), 2.11 (m, 1H), 1.96-2.01 (m, 2H), 1.85-1.92 (m, 1H), 1.73-1.81 (m, 
1H), 1.65 (m, 1H), 1.48 (m, 3H), 1.44 (d, 3H, J = 6.4 Hz), 1.06 (m, 2H), 0.97 (d, 3H, J = 6.0 Hz), 0.58 (d, 
1H, J = 12.4 Hz); 13C NMR (C6D6, 100 MHz) δ 214.4, 159.2, 154.7, 143.6, 139.3, 137.0, 131.8, 128.5, 
126.8, 123.38, 123.35, 114.2, 113.0, 74.3, 66.7, 63.0, 54.8, 51.5, 43.1, 41.8, 40.3, 37.9, 37.8, 37.6, 33.3, 
30.9, 29.8, 21.2, 20.2, 18.8, 17.8; HRMS (FAB+) m/z: Calculated 648.2012, Found 648.2036. 
 
 
Preparation of 10.  
Prepared from S15 (195 mg, 0.294 mmol) and AgOPiv (185 mg, 0.865 mmol) following the 
procedure detailed for 8 providing 10 (55 mg, 28%) as a purple powder: 1H NMR (C6D6, 400 MHz) δ 
15.08 (s, 1H), 7.36 (dd, 1H, J = 1.6, 7.6 Hz), 7.16-7.24 (m, 2H), 6.81-6.87 (m, 2H), 6.51 (d, 1H, J = 8.4 
Hz), 4.58 (hept, 1H, J = 6.2 Hz), 4.09 (s, 1H), 3.10-3.33 (m, 4H), 2.21 (m, 1H), 2.19 (d, 6H, J = 6.0 Hz), 
2.10 (m, 1H), 1.96 (m, 1H), 1.85 (m, 2H), 1.75 (m, 1H), 1.63 (m, 1H), 1.46 (m, 3H), 1.41 (d, 3H, J = 6.4 
Hz), 1.07 (m, 2H), 0.96 (d, 3H, J = 6.0 Hz), 0.54 (d, 1H, J = 12.4 Hz); 13C NMR (C6D6, 100 MHz) δ 265.9, 
214.2, 154.7, 143.5, 140.0, 138.0, 137.4, 133.4, 129.2, 128.6, 127.1, 123.4, 123.3, 113.0, 74.4, 66.7, 
63.2, 51.0, 43.0, 41.8, 40.2, 37.8, 37.7, 37.6, 33.2, 30.9, 29.7, 21.2, 20.2, 18.3, 17.3; HRMS (FAB+) m/z: 
Calculated 652.1517, Found 652.1529. 
 
 
Preparation of 11. 
In a glove box, 2 (52.1 mg, 77.5 µmol), potassium 2,6-diisopropylphenoxide (83.9 mg, 388 µmol) 
and C6H6 (5.0 ml) were added into a 20 ml vial equipped with a stir bar. The reaction mixture was stirred 
at room temperature for 30 min and filtered. The filtrate was evaporated and the resulting solid was 
dissolved in small amount of Et2O and recrystallized at 35 °C. 11 was obtained as dark brown crystals 
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(54 mg, 93%). 1H NMR (500 MHz, C6D6): δ 14.02 (s, 1H), 7.39 (dd, J = 7.3, 1.5 Hz, 1H), 7.15 (br s, 1H), 
7.06 (dt, J = 6.5, 2 Hz, 1H), 6.95 (br s, 1H), 6.83 (q, J = 7.5 Hz, 2H), 6.77 (s, 1H), 6.58-6.57 (m, 2H), 4.32 
(sept, J = 6.4 Hz, 1H), 4.0 (br s, 1H), 3.89 (s, 1H), 3.40 (q, J = 11 Hz, 1H), 3.27 (dt, J = 10.5, 5 Hz, 1H), 
3.10 (m, 2H), 2.57 (s, 3H), 2.33 (s, 3H), 2.30 (br s, 1H), 2.20 (br s, 1H), 2.11 (br s, 1H), 2.03 (s, 3H), 2.01 
(br s, 1H), 1.94-1.93 (m, 1H), 1.82 (br t, J = 9 Hz, 2H), 1.62 (br s, 1H), 1.55-1.38 (m, 9H), 1.25 (d, J = 6.4 
Hz, 3H), 1.11 (br d, J = 10.5 Hz, 2H), 0.85 (d, J = 6.4 Hz, 3H), 0.59-0.41 (br m, 7H). 13C NMR (126 MHz, 
C6D6) δ 234.91, 214.14, 150.56, 140.03, 136.31, 134.41, 134.07, 132.39, 127.15, 126.11, 121.95, 119.99, 
119.76, 112.66, 110.58, 72.80, 66.00, 60.25, 49.43, 40.14, 38.44, 37.35, 34.95, 34.83, 34.23, 30.62, 
27.99, 26.83, 18.48, 18.15, 17.71, 15.97, 15.73. HRMS (FAB+): Calculated: 748.3542, Found: 748.3576. 
 
 
Preparation of 28. 
 In a glovebox, a 20 mL vial was charged with 27 (520 L, 2.5 mmol), 26 (1.13 mL, 25 mmol), and 
THF (1.35 mL). 7 (7.9 mg, 0.0125 mmol, 0.5 mol %) was added and the reaction was stirred at 35 C in 
an open vial for 2 hours. The vial was removed from the glovebox and the solvent was removed in vacuo. 
The crude mixture was chromatographed through silica gel with hexane: ethyl acetate (9:1) to give a 
mixture of the desired product and the 8-nonenyl acetate starting material. This mixture was 
chromatographed on silica gel impregnated with silver (I) nitrate (10%) prepared by the following 
procedure with a mobile phase of hexane: ethyl acetate (9:1). The solvent was removed in vacuo to yield 
pure 28 (404 mg, 77%). IR (NaCl), , cm-1: 3005, 2928, 2865, 1745, 1456, 1386, 1365, 1238, 1038, 967, 
725. 1H NMR (500 MHz, CD2Cl2) δ 5.35 (m, 2H), 4.02 (t, J = 6.8 Hz, 2H), 1.94-2.06 (m, 7H), 1.55-1.67 (m, 
2H), 1.23-1.41 (m, 12H), 0.84-0.93 (m, 3H).13C NMR (126 MHz, CD2Cl2) δ 171.45, 130.43, 130.31, 65.04, 
32.57, 30.26, 29.73, 29.20, 27.69, 27.46, 26.47, 22.93, 21.32, 14.34. HRMS (EI+): Calculated – 241.2168 
Found – 241.2211. 
Preparation of silica impregnated with silver (I) nitrate (10%). 
 In a procedure modified from the literature,5 silver (I) nitrate (5.0 g) was added to ethanol (300 
mL) and enough water (ca. 100 mL) to dissolve the solid. Silica gel (50 g) was then added to this solution 
and vigorously shaken. The solvent was removed under reduced pressure in a rotary evaporator and the 
                                                     
(5) Norin, T.; Westfelt, L. Acta Chem. Scand. 1963, 17, 1828.  
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remaining slurry was covered in foil and dried in an oven at 150C for 6 hours to yield a light gray powder. 
Columns were loaded as with ordinary silica and shielded from light.  
General Procedure for the Determination of Initiation Rates. 
 In a glovebox, a 1 mL volumetric flask was charged with 2 (8.1 mg, 0.012 mmol) and filled to the 
line with C6D6 to create a stock solution (ca. 0.012 M). A portion of the stock solution (0.25 mL, 0.003 
mmol 2) was added to a NMR tube and diluted with C6D6 (0.35 mL). The NMR tube was sealed with a 
septa cap and placed in the NMR spectrometer at 30 °C. Butyl vinyl ether (12 µL, 0.09 mmol) was added 
and the disappearance of the benzylidene proton resonance was monitored by arraying the ‘pad’ function 
in VNMRj.  
All reactions, with the exception of 11, showed clean first-order kinetics over a period of at least 
three half-lives.  Spectra were baseline corrected and integrated with MestReNova. Estimation of error 
was determined from the average of three different kinetic runs.  
General Procedure for Homodimerization Reactions. 
 In a glovebox, a 1 mL volumetric flask was charged with catalyst (0.0981 mmol) and filled to the 
line with THF to create a stock solution (0.0981 M). A portion of the catalyst stock solution (50 L, ca. 5 
mol) was added to a 4 mL vial containing substrate (5 mmol) and THF (1.1 mL, ca. 3 M). The vial was 
placed into an aluminum block (IKA #3904400) preheated to 35 °C using a temperature controlled 
hotplate and the reaction was stirred while open to the glovebox atmosphere. After completion of the 
reaction (determined by 1H NMR spectroscopy), the vial was removed from the glovebox, quenched with 
oxygen, and the product was isolated via flash chromatography on silica gel according to literature 
procedures.6 The percentage of Z-olefin product was determined by 1H and 13C NMR spectroscopy, and 
all spectra were consistent with previous literature reports.6  
General Procedure for Cross-metathesis of 12 and 24. 
 In a glovebox, a 4 mL vial was charged with 12 (1.33 mL, 10 mmol) and tridecane (internal 
standard, 1.22 mL, 5 mmol). A portion (89 L, 0.35 mmol 12) of this stock solution was added to a second 
4 mL vial followed by 24 (111 L, 0.69 mmol) and THF (0.45 mL). This mixture was stirred for several 
minutes before taking a t0 timepoint. An aliquot (50 L, 0.0035 mmol) of a catalyst solution prepared from 
7 (44 mg, 0.069 mmol) in THF (1 mL) was added to the substrate solution and the vial was sealed and 
heated to the desired temperature. Periodically, the reaction was cooled to RT, and an aliquot (20 L) 
was removed from the glovebox, diluted with a solution of ethyl vinyl ether in CH2Cl2, and analyzed via 
GC.  
                                                     
(6)  Keitz, B. K.; Endo, K.; Herbert, M. B.; Grubbs, R. H. J. Am. Chem. Soc. 2011, 133, 9686. 
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 GC response factors for all starting materials and products (ethylene excluded) were obtained in 
order to determine accurate conversions (Figure S1) and the GC data was worked up according to the 
literature.7 
 GC instrument conditions: Inlet temperature – 250 °C; Detector temperature – 250 °C; hydrogen 
flow – 32 mL/min; air flow – 400 mL/min; consant col + makeup flow – 30 mL/min. 
 GC Method: 50 °C for 5 min, followed by a temperature increase of 10 °C/min to 240 °C and a 




Figure S1. Response factors for 12 (top left), 24 (top right), 25 (bottom left), and 13 (bottom right). 
 
 
                                                     




































































Figure S2. Time-course plot for the conversion (A) and selectivity (B) of 12 to 13 with catalysts 7-10. 
 




Figure S4. ROMP comparison of cyclooctadiene (COD) with catalysts 1 and 4. Conditions were 1 or 4 (0.1 mol%) 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S25. 1H-1H COSY (CD2Cl2) of 28. 
 
Figure S26. 1H-13C HSQC (CD2Cl2) of 28. 
